Read + Share
Amedeo Smart
Independent Medical Education
Nissen SE. Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease-Reply. JAMA 2025 Mar 27. doi: 10.1001/jama.2025.0034.PMID: 40146122
Email
LinkedIn
Privacy Policy